Human Mas-Related G Protein-Coupled Receptors-X1 Induce Chemokine Receptor 2 Expression in Rat Dorsal Root Ganglia Neurons and Release of Chemokine Ligand 2 from the Human LAD-2 Mast Cell Line

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Solinski, Hans Jürgen ^a   Petermann, Franziska ^b   Rothe, Kathrin ^a   Boekhoff, Ingrid ^a   Gudermann, Thomas ^a   Breit, Andreas ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN; CHEMOKINE RECEPTOR CCR2; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; EARLY GROWTH RESPONSE FACTOR 1; G PROTEIN COUPLED RECEPTOR; MAS RELATED G PROTEIN COUPLED RECEPTOR X1; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN C FOS; SERUM RESPONSE FACTOR; T CELL FACTOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CHRONIC PAIN; CONTROLLED STUDY; CYTOKINE RELEASE; EMBRYO; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENE EXPRESSION; GENE INDUCTION; HUMAN; HUMAN CELL; INFLAMMATORY PAIN; INTRACELLULAR SIGNALING; MAST CELL; MOLECULAR PATHOLOGY; MOUSE; NEUROPATHIC PAIN; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; RECEPTOR UPREGULATION; SPINAL GANGLION;

ANIMALS; BRADYKININ; CALCINEURIN; CALCIUM; CELL LINE; CHEMOKINE CCL2; EARLY GROWTH RESPONSE PROTEIN 1; ENZYME ACTIVATION; GANGLIA, SPINAL; GENE EXPRESSION REGULATION; GENES, FOS; HEK293 CELLS; HUMANS; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; MAST CELLS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NFATC TRANSCRIPTION FACTORS; PEPTIDE FRAGMENTS; RATS; RECEPTORS, CCR2; RECEPTORS, G-PROTEIN-COUPLED; SENSORY RECEPTOR CELLS; SERUM RESPONSE FACTOR; TERNARY COMPLEX FACTORS;

EID: 84874741963     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058756     Document Type: Article

References (69)

1. Lembo PM, Grazzini E, Groblewski T, O'Donnell D, Roy MO, et al. (2002) Proenkephalin A gene products activate a new family of sensory neuron - specific GPCRs. Nat Neurosci 5: 201-209.
2. Dong X, Han S, Zylka MJ, Simon MI, Anderson DJ, (2001) A diverse family of GPCRs expressed in specific subsets of nociceptive sensory neurons. Cell 106: 619-632.
3. Tatemoto K, Nozaki Y, Tsuda R, Konno S, Tomura K, et al. (2006) Immunoglobulin E-independent activation of mast cell is mediated by Mrg receptors. Biochem Biophys Res Commun 349: 1322-1328.
4. Subramanian H, Kashem SW, Collington SJ, Qu H, Lambris JD, et al. (2011) PMX-53 as a dual CD88 antagonist and an agonist for Mas-related gene 2 (MrgX2) in human mast cells. Mol Pharmacol 79: 1005-1013.
5. Breit A, Gagnidze K, Devi LA, Lagace M, Bouvier M, (2006) Simultaneous activation of the delta opioid receptor (deltaOR)/sensory neuron-specific receptor-4 (SNSR-4) hetero-oligomer by the mixed bivalent agonist bovine adrenal medulla peptide 22 activates SNSR-4 but inhibits deltaOR signaling. Mol Pharmacol 70: 686-696.
6. Solinski HJ, Boekhoff I, Bouvier M, Gudermann T, Breit A, (2010) Sensory neuron-specific MAS-related gene-X1 receptors resist agonist-promoted endocytosis. Mol Pharmacol 78: 249-259.
7. Burstein ES, Ott TR, Feddock M, Ma JN, Fuhs S, et al. (2006) Characterization of the Mas-related gene family: structural and functional conservation of human and rhesus MrgX receptors. Br J Pharmacol 147: 73-82.
8. Solinski HJ, Zierler S, Gudermann T, Breit A (2012) Human sensory neuron-specific Mas-related G protein-coupled receptors-X1 sensitize and directly activate transient receptor potential cation channel V1 via distinct signaling pathways. J Biol Chem.
9. Sikand P, Dong X, Lamotte RH, (2011) BAM8-22 Peptide Produces Itch and Nociceptive Sensations in Humans Independent of Histamine Release. J Neurosci 31: 7563-7567.
10. Chen H, Ikeda SR, (2004) Modulation of ion channels and synaptic transmission by a human sensory neuron-specific G-protein-coupled receptor, SNSR4/mrgX1, heterologously expressed in cultured rat neurons. J Neurosci 24: 5044-5053.
11. Andrisani OM, (1999) CREB-mediated transcriptional control. Crit Rev Eukaryot Gene Expr 9: 19-32.
12. Buchwalter G, Gross C, Wasylyk B, (2004) Ets ternary complex transcription factors. Gene 324: 1-14.
13. Shaywitz AJ, Greenberg ME, (1999) CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu Rev Biochem 68: 821-861.
14. Davis RJ, (1995) Transcriptional regulation by MAP kinases. Mol Reprod Dev 42: 459-467.
15. Seybold VS, Coicou LG, Groth RD, Mermelstein PG, (2006) Substance P initiates NFAT-dependent gene expression in spinal neurons. J Neurochem 97: 397-407.
16. Jackson JG, Usachev YM, Thayer SA, (2007) Bradykinin-induced nuclear factor of activated T-cells-dependent transcription in rat dorsal root ganglion neurons. Mol Pharmacol 72: 303-310.
17. Groth RD, Coicou LG, Mermelstein PG, Seybold VS, (2007) Neurotrophin activation of NFAT-dependent transcription contributes to the regulation of pro-nociceptive genes. J Neurochem 102: 1162-1174.
18. Knoll B, Nordheim A, (2009) Functional versatility of transcription factors in the nervous system: the SRF paradigm. Trends Neurosci 32: 432-442.
19. Maldonado R, Blendy JA, Tzavara E, Gass P, Roques BP, et al. (1996) Reduction of morphine abstinence in mice with a mutation in the gene encoding CREB. Science 273: 657-659.
20. Kerr N, Pintzas A, Holmes F, Hobson SA, Pope R, et al. (2010) The expression of ELK transcription factors in adult DRG: Novel isoforms, antisense transcripts and upregulation by nerve damage. Mol Cell Neurosci 44: 165-177.
21. Taylor DA, Fleming WW, (2001) Unifying perspectives of the mechanisms underlying the development of tolerance and physical dependence to opioids. J Pharmacol Exp Ther 297: 11-18.
22. Bhangoo S, Ren D, Miller RJ, Henry KJ, Lineswala J, et al. (2007) Delayed functional expression of neuronal chemokine receptors following focal nerve demyelination in the rat: a mechanism for the development of chronic sensitization of peripheral nociceptors. Mol Pain 3: 38.
23. Bhangoo SK, Ripsch MS, Buchanan DJ, Miller RJ, White FA, (2009) Increased chemokine signaling in a model of HIV1-associated peripheral neuropathy. Mol Pain 5: 48.
24. Baubet V, Le Mouellic H, Campbell AK, Lucas-Meunier E, Fossier P, et al. (2000) Chimeric green fluorescent protein-aequorin as bioluminescent Ca2+ reporters at the single-cell level. Proc Natl Acad Sci U S A 97: 7260-7265.
25. Francel PC, Harris K, Smith M, Fishman MC, Dawson G, et al. (1987) Neurochemical characteristics of a novel dorsal root ganglion × neuroblastoma hybrid cell line, F-11. J Neurochem 48: 1624-1631.
26. Kirshenbaum AS, Akin C, Wu Y, Rottem M, Goff JP, et al. (2003) Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; activation following aggregation of FcepsilonRI or FcgammaRI. Leuk Res 27: 677-682.
27. Jung H, Miller RJ, (2008) Activation of the nuclear factor of activated T-cells (NFAT) mediates upregulation of CCR2 chemokine receptors in dorsal root ganglion (DRG) neurons: a possible mechanism for activity-dependent transcription in DRG neurons in association with neuropathic pain. Mol Cell Neurosci 37: 170-177.
28. White FA, Bhangoo SK, Miller RJ, (2005) Chemokines: integrators of pain and inflammation. Nat Rev Drug Discov 4: 834-844.
29. Rothe K, Solinski HJ, Boekhoff I, Gudermann T, Breit A, (2012) Morphine activates the ELK-1/SRF pathway via ERK-1/2 in F11 cells derived from dorsal root ganglia neurons. J Pharmacol Exp Ther 342: 41-52.
30. Katayama N, Iwata E, Sakurai H, Tsuchiya T, Tsuda M, (1993) Additive induction of Egr-1 (zif/268) mRNA expression in neuroblastoma × glioma hybrid NG108-15 cells via cholinergic muscarinic, alpha 2-adrenergic, and bradykinin receptors. J Neurochem 60: 902-907.
31. Jamieson GA Jr, Mayforth RD, Villereal ML, Sukhatme VP, (1989) Multiple intracellular pathways induce expression of a zinc-finger encoding gene (EGR1): relationship to activation of the Na/H exchanger. J Cell Physiol 139: 262-268.
32. Hao L, Ge X, Wan H, Hu S, Lercher MJ, et al. (2012) Human functional genetic studies are biased against the medically most relevant primate-specific genes. BMC Evol Biol 10: 316.
33. Fatakia SN, Costanzi S, Chow CC, (2011) Molecular evolution of the transmembrane domains of G protein-coupled receptors. PLoS One 6: e27813.
34. Vallender EJ, Lahn BT, (2004) Positive selection on the human genome. Hum Mol Genet 13 Spec No 2: R245-254.
35. Fan SF, Shen KF, Scheideler MA, Crain SM, (1992) F11 neuroblastoma × DRG neuron hybrid cells express inhibitory mu- and delta-opioid receptors which increase voltage-dependent K+ currents upon activation. Brain Res 590: 329-333.
36. Jow F, He L, Kramer A, Hinson J, Bowlby MR, et al. (2006) Validation of DRG-like F11 cells for evaluation of KCNQ/M-channel modulators. Assay Drug Dev Technol 4: 49-56.
37. Puttfarcken PS, Manelli AM, Arneric SP, Donnelly-Roberts DL, (1997) Evidence for nicotinic receptors potentially modulating nociceptive transmission at the level of the primary sensory neuron: studies with F11 cells. J Neurochem 69: 930-938.
38. McIlvain HB, Baudy A, Sullivan K, Liu D, Pong K, et al. (2006) Pituitary adenylate cyclase-activating peptide (PACAP) induces differentiation in the neuronal F11 cell line through a PKA-dependent pathway. Brain Res 1077: 16-23.
39. Boland LM, Allen AC, Dingledine R, (1991) Inhibition by bradykinin of voltage-activated barium current in a rat dorsal root ganglion cell line: role of protein kinase C. J Neurosci. 11: 1140-1149.
40. Li Y, Ji A, Weihe E, Schafer MK, (2004) Cell-specific expression and lipopolysaccharide-induced regulation of tumor necrosis factor alpha (TNFalpha) and TNF receptors in rat dorsal root ganglion. J Neurosci 24: 9623-9631.
41. Gaudioso C, Hao J, Martin-Eauclaire MF, Gabriac M, Delmas P, (2012) Menthol pain relief through cumulative inactivation of voltage-gated sodium channels. Pain 153: 473-484.
42. Eijkelkamp N, Heijnen CJ, Willemen HL, Deumens R, Joosten EA, et al. (2010) GRK2: a novel cell-specific regulator of severity and duration of inflammatory pain. J Neurosci 30: 2138-2149.
43. Fioravanti B, De Felice M, Stucky CL, Medler KA, Luo MC, et al. (2008) Constitutive activity at the cannabinoid CB1 receptor is required for behavioral response to noxious chemical stimulation of TRPV1: antinociceptive actions of CB1 inverse agonists. J Neurosci 28: 11593-11602.
44. Bullitt E, (1989) Induction of c-fos-like protein within the lumbar spinal cord and thalamus of the rat following peripheral stimulation. Brain Res 493: 391-397.
45. Romero A, Gonzalez-Cuello A, Laorden ML, Campillo A, Vasconcelos N, et al. (2012) Effects of surgery and/or remifentanil administration on the expression of pERK1/2, c-Fos and dynorphin in the dorsal root ganglia in mice. Naunyn Schmiedebergs Arch Pharmacol 385: 397-409.
46. Utreras E, Futatsugi A, Rudrabhatla P, Keller J, Iadarola MJ, et al. (2009) Tumor necrosis factor-alpha regulates cyclin-dependent kinase 5 activity during pain signaling through transcriptional activation of p35. J Biol Chem 284: 2275-2284.
47. Kendall G, Ensor E, Brar-Rai A, Winter J, Latchman DS, (1994) Nerve growth factor induces expression of immediate-early genes NGFI-A (Egr-1) and NGFI-B (nur 77) in adult rat dorsal root ganglion neurons. Brain Res Mol Brain Res 25: 73-79.
48. Ko SW, Vadakkan KI, Ao H, Gallitano-Mendel A, Wei F, et al. (2005) Selective contribution of Egr1 (zif/268) to persistent inflammatory pain. J Pain 6: 12-20.
49. Dolan S, Hastie P, Crossan C, Nolan AM, (2011) Co-induction of cyclooxygenase-2 [correction of cyclooxyenase-2] and early growth response gene (Egr-1) in spinal cord in a clinical model of persistent inflammation and hyperalgesia. Mol Pain 7: 91.
50. Groth RD, Mermelstein PG, (2003) Brain-derived neurotrophic factor activation of NFAT (nuclear factor of activated T-cells)-dependent transcription: a role for the transcription factor NFATc4 in neurotrophin-mediated gene expression. J Neurosci 23: 8125-8134.
51. Genazzani AA, Carafoli E, Guerini D, (1999) Calcineurin controls inositol 1,4,5-trisphosphate type 1 receptor expression in neurons. Proc Natl Acad Sci U S A 96: 5797-5801.
52. Abbadie C, Lindia JA, Cumiskey AM, Peterson LB, Mudgett JS, et al. (2003) Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2. Proc Natl Acad Sci U S A 100: 7947-7952.
53. Serrano A, Pare M, McIntosh F, Elmes SJ, Martino G, et al. (2012) Blocking spinal CCR2 with AZ889 reversed hyperalgesia in a model of neuropathic pain. Mol Pain 6: 90.
54. Sun JH, Yang B, Donnelly DF, Ma C, LaMotte RH, (2006) MCP-1 enhances excitability of nociceptive neurons in chronically compressed dorsal root ganglia. J Neurophysiol 96: 2189-2199.
55. White FA, Sun J, Waters SM, Ma C, Ren D, et al. (2005) Excitatory monocyte chemoattractant protein-1 signaling is up-regulated in sensory neurons after chronic compression of the dorsal root ganglion. Proc Natl Acad Sci U S A 102: 14092-14097.
56. Wang CH, Zou LJ, Zhang YL, Jiao YF, Sun JH, (2010) The excitatory effects of the chemokine CCL2 on DRG somata are greater after an injury of the ganglion than after an injury of the spinal or peripheral nerve. Neurosci Lett 475: 48-52.
57. Jung H, Bhangoo S, Banisadr G, Freitag C, Ren D, et al. (2009) Visualization of chemokine receptor activation in transgenic mice reveals peripheral activation of CCR2 receptors in states of neuropathic pain. J Neurosci 29: 8051-8062.
58. Zimmerman B, Simaan M, Akoume MY, Houri N, Chevallier S, et al. (2011) Role of ssarrestins in bradykinin B2 receptor-mediated signalling. Cell Signal 23: 648-659.
59. Pierce KL, Lefkowitz RJ, (2001) Classical and new roles of beta-arrestins in the regulation of G-protein-coupled receptors. Nat Rev Neurosci 2: 727-733.
60. Skaper SD, Giusti P, Facci L (2012) Microglia and mast cells: two tracks on the road to neuroinflammation. Faseb J.
61. Grazzini E, Puma C, Roy MO, Yu XH, O'Donnell D, et al. (2004) Sensory neuron-specific receptor activation elicits central and peripheral nociceptive effects in rats. Proc Natl Acad Sci U S A 101: 7175-7180.
62. Brinkmann M, Lutkemeyer D, Gudermann F, Lehmann J, (2002) New technologies for automated cell counting based on optical image analysis; The Cellscreen'. Cytotechnology 38: 119-127.
63. Strasser A, Wittmann HJ, Buschauer A, Schneider EH, Seifert R, (2013) Species-dependent activities of G-protein-coupled receptor ligands: lessons from histamine receptor orthologs. Trends Pharmacol Sci 34: 13-32.
64. Hudson BD, Tikhonova IG, Pandey SK, Ulven T, Milligan G, (2012) Extracellular ionic locks determine variation in constitutive activity and ligand potency between species orthologs of the free fatty acid receptors FFA2 and FFA3. J Biol Chem 287: 41195-41209.
65. Jenkins L, Brea J, Smith NJ, Hudson BD, Reilly G, et al. (2012) Identification of novel species-selective agonists of the G-protein-coupled receptor GPR35 that promote recruitment of beta-arrestin-2 and activate Galpha13. Biochem J 432: 451-459.
66. Wainscott DB, Little SP, Yin T, Tu Y, Rocco VP, et al. (2007) Pharmacologic characterization of the cloned human trace amine-associated receptor1 (TAAR1) and evidence for species differences with the rat TAAR1. J Pharmacol Exp Ther 320: 475-485.
67. Li J, Li JG, Chen C, Zhang F, Liu-Chen LY, (2002) Molecular basis of differences in (-) (trans)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidiny)-cyclohexyl]benzeneacetamide- induced desensitization and phosphorylation between human and rat kappa-opioid receptors expressed in Chinese hamster ovary cells. Mol Pharmacol 61: 73-84.
68. Moore JJ Jr, Whitsett JA, (1982) The beta-adrenergic receptor in mammalian placenta: species differences and ontogeny. Placenta 3: 257-268.
69. Kunapuli P, Lee S, Zheng W, Alberts M, Kornienko O, et al. (2006) Identification of small molecule antagonists of the human mas-related gene-X1 receptor. Anal Biochem 351: 50-61.